Behavioral Intervention
High-Intensity Interval Training for HIV/AIDS
University of Alabama at Birmingham, Birmingham, AL
Targeting 3 different conditionsHigh-Intensity Interval Training +1 moreN/AWaitlist AvailableLed by Raymond Jones, Ph.D.Research Sponsored by University of Alabama at BirminghamEligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Sedentary lifestyle, defined as < 150 min/wk moderate physical activity as assessed by CHAMPS questionnaire
Neurocognitive Impairment (as assessed using the BRACE+
Must not have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Upbaseline, up to 12 weeks, 3-months post-intervention
Awards & highlights
No Placebo-Only Group
Study Summary
This trial will study if exercise can help people 50+ living with HIV who have suboptimal cognition. 60 participants in Alabama will be monitored over 3 months to measure the effects of exercise.
Eligible Conditions
- HIV/AIDS
- Arterial Stiffness
- Cognitive Impairment
Eligibility Criteria
Inclusion Criteria
You will be eligible if you check “Yes” for the criteria belowSelect...
You are not physically active and do less than 150 minutes of moderate exercise per week, as determined by a questionnaire.
Select...
You have difficulty thinking, learning, or remembering things, which is assessed using a test called BRACE+.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline, up to 12 weeks, 3-months post-intervention
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, up to 12 weeks, 3-months post-intervention
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in cognitive function
Change in vascular function
Secondary outcome measures
Barriers to Engagement in Exercise
Perceptions of the Study and Exercise Interventions
Other outcome measures
Participant Safety, Adherence to the Intervention, Retention
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: High-Intensity Interval TrainingExperimental Treatment1 Intervention
Group II: Continuous Moderate ExerciseActive Control1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
High-Intensity Interval Training
2019
N/A
~570
Find a site
Who is running the clinical trial?
University of Alabama at BirminghamLead Sponsor
1,509 Previous Clinical Trials
2,256,911 Total Patients Enrolled
Raymond Jones, Ph.D.Principal Investigator
University of Alabama at BirminghamMedia Library
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is this exploration actively calling for new participants?
"According to the details posted on clinicaltrials.gov, this specific medical investigation is not admitting patients presently. The protocol for enrollment was first published in September of 2023 and last revised at the end of July that year; however, there are still 836 other studies recruiting participants right now."
Answered by AI
Recent research and studies